FDA Inspection 1027891 — Southern California Reproductive Center Medical Group PC
The FDA completed an inspection of Southern California Reproductive Center Medical Group PC on Aug 24, 2017 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Beverly Hills, CA (United States)